DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0684249 | Carcinoma of lung | LPIN1 | 23175 | lipin 1 | Q14693 |
C0162309 | Adrenoleukodystrophy | LPIN1 | 23175 | lipin 1 | Q14693 |
C0242379 | Malignant neoplasm of lung | LPIN1 | 23175 | lipin 1 | Q14693 |
C0887850 | Polycystic Kidney, Type 1 Autosomal Dominant Disease | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0085413 | Polycystic Kidney, Autosomal Dominant | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C3887964 | POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0026769 | Multiple Sclerosis | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0014070 | Encephalomyelitis | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0029408 | Degenerative polyarthritis | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0158683 | Polycystic liver disease | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0023895 | Liver diseases | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0022680 | Polycystic Kidney Diseases | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C2751306 | Polycystic kidney disease, type 2 | GANAB | 23193 | glucosidase II alpha subunit | Q14697 |
C0022104 | Irritable Bowel Syndrome | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0220597 | Adult Hodgkin Lymphoma | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0678222 | Breast Carcinoma | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0024291 | Lymphohistiocytosis, Hemophagocytic | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0023434 | Chronic Lymphocytic Leukemia | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0162309 | Adrenoleukodystrophy | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C3160718 | PARKINSON DISEASE, LATE-ONSET | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0026764 | Multiple Myeloma | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0024299 | Lymphoma | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0020179 | Huntington Disease | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C0021051 | Immunologic Deficiency Syndromes | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
C1306459 | Primary malignant neoplasm | ACSBG1 | 23205 | acyl-CoA synthetase bubblegum family member 1 | Q96GR2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024